Impact of the serum ferritin concentration in liver transplantation

Liver Transpl. 2015 Nov;21(11):1419-27. doi: 10.1002/lt.24222.

Abstract

The serum ferritin (SF) concentration is a widely available and objective laboratory parameter. SF is also widely recognized as an acute-phase reactant. The purpose of the present study was to identify the chronological changes in the recipient's SF concentration during liver transplantation (LT) and to clarify factors having an effect on the recipient's intraoperative SF level. In addition, the study retrospectively evaluated the usefulness of measuring SF during LT. Ninety-eight pediatric recipients were retrospectively analyzed. The data were analyzed and compared according to the SF level in the recipient. Patients were classified into 2 groups based on the intraoperative peak SF levels of ≤ 1000 ng/mL (low-SF group) or >1000 ng/mL (high-SF group). The SF value increased dramatically after reperfusion and fell to normal levels within the early postoperative period. The warm ischemia time (WIT) was significantly longer in the high-SF group (47.0 versus 58.5 minutes; P = 0.003). In addition, a significant positive correlation was observed between the peak SF value and WIT (r = 0.35; P < 0.001). There were significant positive correlations between the peak SF value and the donors' preoperative laboratory data, including transaminases, cholinesterase, hemoglobin, transferrin saturation, and SF, of which SF showed the strongest positive correlation (r = 0.74; P < 0.001). The multivariate analysis revealed that WIT and donor's SF level were a significant risk factor for high SF level in the recipient (P = 0.007 and 0.02, respectively). In conclusion, the SF measurement can suggest the degree of ischemia/reperfusion injury (IRI). A high SF level in the donor is associated with the risk of further acute reactions, such as IRI, in the recipient.

MeSH terms

  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Female
  • Ferritins / blood*
  • Follow-Up Studies
  • Graft Rejection / blood*
  • Graft Rejection / epidemiology
  • Graft Rejection / etiology
  • Humans
  • Immunosuppression Therapy / methods*
  • Incidence
  • Infant
  • Japan / epidemiology
  • Liver Transplantation / adverse effects*
  • Living Donors
  • Male
  • Monitoring, Intraoperative / methods
  • Prognosis
  • Reperfusion Injury / blood*
  • Reperfusion Injury / complications
  • Reperfusion Injury / prevention & control
  • Retrospective Studies
  • Survival Rate / trends
  • Time Factors

Substances

  • Biomarkers
  • Ferritins